KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 162 filers reported holding KARUNA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,319,917 | -19.5% | 7,806 | +3.2% | 0.00% | 0.0% |
| Q2 2023 | $1,640,484 | +74.4% | 7,565 | +46.1% | 0.00% | +100.0% |
| Q1 2023 | $940,529 | +21.0% | 5,178 | +30.9% | 0.00% | 0.0% |
| Q4 2022 | $777,585 | +16.6% | 3,957 | +33.4% | 0.00% | 0.0% |
| Q3 2022 | $667,000 | +75.5% | 2,966 | -1.2% | 0.00% | 0.0% |
| Q2 2022 | $380,000 | -7.8% | 3,003 | -7.5% | 0.00% | 0.0% |
| Q1 2022 | $412,000 | -20.3% | 3,246 | -17.7% | 0.00% | 0.0% |
| Q4 2021 | $517,000 | +18.3% | 3,946 | +10.5% | 0.00% | 0.0% |
| Q3 2021 | $437,000 | +7.4% | 3,571 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $407,000 | -5.1% | 3,571 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $429,000 | +99.5% | 3,571 | +68.8% | 0.00% | – |
| Q4 2020 | $215,000 | -39.9% | 2,116 | -54.3% | 0.00% | -100.0% |
| Q3 2020 | $358,000 | -46.1% | 4,631 | -22.2% | 0.00% | -50.0% |
| Q2 2020 | $664,000 | +52.6% | 5,951 | -1.7% | 0.00% | +100.0% |
| Q1 2020 | $435,000 | – | 6,054 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |